Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer. Read more

Catch up on all the news from the July 2018 NRG Oncology Semiannual Meeting. A special edition newsletter is now posted. Read more

The recording of the NRG Oncology Digital Health and Personal Connected Health Minisymposium is now posted. Read more 

NRG Oncology Newsletter Vol. 3 2018 now posted Read more

StereotacticBody Radiation Therapy (SBRT) May be an Effective and Safe Alternative for Patients with Medically Operable Early-Stage Lung Cancer Read more

MGMT Promoter Methylation Associated with Improved Survival for Patients with WHO Grade II Gliomas Read more

An Important Word from Quality Assurance staff about Protocol Amendments Read more

Dr. Chakravarti Selected to Serve on NCI Advisory Board of Scientific Counselors Read more

Dr. Felix Feng Selected as the New NRG Oncology Genitourinary Cancer Committee Chair Read more

Drs. Fisher & Wolmark receive SSO 2018 Charles M. Balch, MD Distinguished Service Award. Read more

NRG Oncology/RTOG 0126: Higher-Dose Radiotherapy Lowers Risk of Recurrence but Does Not Improve Survival for Men with Prostate Cancer Read more

Project Team Member Application for Radium-223 now posted. Forms are due by March 22, 2018. Read more

NRG Oncology Appoints NCORP Investigator, Matthew Hudson, as Cancer Care Delivery Research  Committee Co-Chair Read more

Aghajanian Appointed as NRG Oncology Gynecologic Cancer Committee Chair Read more

Press Release Issued Regarding NRG Oncology's New Executive Director, Kati Stoermer Read more

NRG Oncology Newsletter Volume 1, 2018 is now available! Read more

Trastuzumab does not negatively impact cardiac function for women with breast cancer in long-term follow-up Read more

New threat for those who publish: PREDATORY JOURNALS.  Read about this evolving issue under "Publications: Publication Updates" Read more

Antiangiogenesis Therapy Improves Overall Survival for Patients with Advanced Cervical Carcinoma Read more

Knowledge-Based Planning Model Aids Clinical Trial Outcomes Read more

MGMT Promoter Predicts Overall Survival for Patients with Anaplastic Astrocytoma Read more

Phase III trial confirms pelvic radiation as standard of care for high-risk, early-stage endometrial cancer Read more

Nomograms Developed and Validated for Patients with Squamous Cell Carcinoma of Larynx by NRG Oncology Read more

Results of NRG Oncology SBRT Comparison Trial for Lung Cancer Patients Consistent after Long-term Follow-up Read more

First Study of Its Kind Depicts Benefits of Brachytherapy for Patients with recurrent Prostate Cancer after EBRT Read more

Results Robert S. Mannel, MD Appointed as an NRG Oncology Group Chairman. Read more